scorecardresearch
Monday, September 30, 2024
HomeBusiness

Business

US drug regulator halts Sun Pharma trials on dermatological drug

Sun Pharma, India's largest drugmaker by revenue, acquired deuruxolitinib when it bought US-based Concert Pharmaceuticals for $576 million earlier this year.

Oil slips on weak China demand fears, U.S. rate rise forecast

By Emily Chow SINGAPORE (Reuters) -Oil prices fell in Asian trade on Tuesday, extending losses seen in the previous session, as weak economic data from China and expectations of a U.S. interest rate

Yen sinks to 15-year low vs euro, Aussie jumps as central banks diverge

By Kevin Buckland TOKYO (Reuters) - The yen continued its steep descent on Tuesday, reaching a 15-year low to the euro, as the implications of a steadfastly dovish Bank of Japan continued to

Stocks on edge, Aussie surges after RBA surprise

By Tom Westbrook SINGAPORE (Reuters) - Asian shares wobbled in cautious trade on Tuesday ahead of a series of data releases and central bank meetings, which began with a surprise rate hike in

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

Oil holds steady as economic fears weigh against potential crude draw

By Laura Sanicola and Emily Chow (Reuters) -Oil prices held steady during Asian trade on Tuesday amid mixed data from China, and as the market weighed forecasts of declining crude stockpiles with

Sun Pharma says U.S. FDA puts partial clinical hold on its dermatological drug

BENGALURU (Reuters) - Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its application for an

Stocks on edge as traders wait on central bankers

By Tom Westbrook SINGAPORE (Reuters) - Asian shares wobbled in cautious trade on Tuesday, while the dollar was firm ahead of a series of data releases and central bank meetings that begins with the

Yen sinks to 15-year low vs euro as dovish BOJ contrasts with ECB

By Kevin Buckland TOKYO (Reuters) - The yen continued its steep descent on Tuesday, reaching a 15-year low to the euro, as the implications of a steadfastly dovish Bank of Japan kept foreign exchange

Oil falls as economic fears weigh against potential crude draw

By Laura Sanicola (Reuters) - Oil prices fell in thin early Asian trade on Tuesday as the market digests weak economic data from China and expectations of another U.S. interest rate hike. Brent crude

On Camera

PM Modi is rescuer of India’s stolen heritage. He’s reclaiming country’s past, lost identity

India’s rich cultural heritage is a vital component of its national identity. The ongoing efforts toward repatriation and global cooperation signify hope for the future.

After a brief surge, private investment & hiring has again turned cautious. Focus is on cutting debt

Financial year 2022-23 saw private investments & hiring surge, but since then firms are using cash to reduce debt. General elections didn’t help matters, either.

Morocco signs pact with Tata for joint manufacture of WhAP Infantry Fighting Vehicle

The armoured platform is India's first amphibious infantry combat wheeled vehicle. Last year, the Royal Moroccan Armed Forces had procured 90 military trucks from the Tata Group.

Islam doesn’t kill democracy. The army-Islam combo does

How come Indonesia, Malaysia, Turkey and Sri Lanka remain constitutional, democratic and stable despite Islam and Buddhism respectively, but Pakistan, Bangladesh and Myanmar don’t?